Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Oligo-metastatic neoPlasms From the gastRo-intEstinal Tract: iDentIfiCaTIon Of cliNical and Molecular Drivers: the PREDICTION Study

NCT05806151 is registered in ClinicalTrials.gov with National Cancer Institute, Naples as lead sponsor.

NCT NCT05806151
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05806151 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Oligo-metastatic neoPlasms From the gastRo-intEstinal Tract: iDentIfiCaTIon Of cliNical and Molecular Drivers: the PREDICTION Study
Lead sponsor
National Cancer Institute, Naples
Phase
Observational
Overall status
Unknown status
Start date
January 17, 2023
Completion date
March 31, 2026
Enrollment
32 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

oligometastatic disease